Get the latest Science News and Discoveries

FDA approves new Alzheimer's treatment, donanemab from Eli Lilly

FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.

None

Related news:

FDA Approves Eli Lilly's New Alzheimer's Drug For Early Disease Symptoms

A new target for treatment of one type of macular degeneration

Treatment with a mixture of antimicrobial peptides can impede antibiotic resistance - EurekAlert